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Summary
We tested the hypothesis that the effects on gene expression of altered DNA methylation by 5-aza-2-deoxycytidine (5-aza-
CdR) and genetic (DNMT knockout) manipulation of DNA are similar, and distinct from Trichostatin A (TSA)-induced
chromatin decondensation. Surprisingly, the effects of 5-aza-CdR were more similar to those of TSA than to DNMT1,
DNMT3B, or double DNMT somatic cell knockout. Furthermore, the effects of 5-aza-CdR were similar at one and five days
exposure, suggesting active demethylation or direct influence of both drugs on the stability of methylation and/or chromatin
marks. Agents that induce gene activation through hypomethylation may have unintended consequences, since nearly as
many genes were downregulated as upregulated after demethylation. In addition, a 75 kb cluster of metallothionein genes
was coordinately regulated.
Introduction ity (Schmid et al., 1984; Lengauer et al., 1998; Tamaru and
Selker, 2001).
Since the initial discovery of altered methylation in human can- The chemical agents used to modulate the expression of
cer (Feinberg and Vogelstein, 1983), a host of epigenetic alter- individual genes in most experimental studies of the cancer
ations have been found, including global hypomethylation, gene epigenome have been either 5-aza-CdR, an inhibitor of DNA
hypomethylation and hypermethylation, and loss of imprinting methylation, or TSA, an inhibitor of histone deacetylation (Egger
(Goelz et al., 1985; Feinberg and Tycko, 2004). Hypermethyla- et al., 2004). However, the agents used in such studies may
tion of the promoters of tumor suppressor genes was first ob- target one methyltransferase or chromatin compaction prefer-
served in retinoblastoma (Greger et al., 1989; Sakai et al., 1991) entially over another and exhibit nonspecific pharmacological
and associated with their silencing (Ohtani-Fujita et al., 1993). effects on gene expression. Thus, a genetic approach to inhibit
Silencing with hypermethylation has been found in many other specific methyltransferases may represent a more rigorous ex-
genes since, and gene activation and chromosomal instability perimental methodology.
have been associated with hypomethylation (Feinberg and It appears that methylation patterns in mammalian cells are
Tycko, 2004). While methylation itself may be one mechanism regulated via a complex interplay of at least three independently
for altered gene expression, other plausible processes include encoded DNA methyltransferases (DNMTs): DNMT1, DNMT3A,
and DNMT3B (Bestor, 2000; Robertson, 2001; Rhee et al., 2002).alterations in chromatin structure resulting in altered gene activ-
S I G N I F I C A N C E
Most experimental studies of the cancer epigenome have employed 5-aza-CdR, an inhibitor of DNA methylation that is presumed
to be specific. Other studies have used TSA that inhibits histone deacetylase and subsequently alters chromatin compaction. Still
other recent studies have employed a genetic approach, using single and double somatic cell knockouts of DNA methyltransferases
1 and 3B. To our knowledge, however, pharmacological and genetic manipulations have not been performed within the same
context to date, preventing the precise definition of their shared or distinctive effects on gene expression. A multimodality experimental
approach combined with a comprehensive expression analysis should reveal the relationship between chemical and genetic
manipulation of the epigenome, as well as unexpected relationships among the gene targets themselves.
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Somatic knockout cell lines for methyltransferase (DNMT1/, met a union of conditions: (1) they showed statistically significant
differences using a Mann-Whitney U-Test (p  0.05, not cor-DNMT3B/, and double knockouts [DKO]) have been con-
rected for multiplicity), and (2) they exhibited a minimum 1.5-structed previously (Rhee et al., 2002) and represent an ideal
fold difference in expression, relative to control. Three additionalmodel system to investigate the epigenetic regulation of gene
analysis methods were employed to validate statistical integrity:expression. It has previously been shown that DNMT1 and
class comparison, class prediction, and false discovery, all per-DNMT3B cooperatively maintain DNA methylation and gene
formed at p  0.05 (see Supplemental Tables S2 and S3). Thesilencing (Rhee et al., 2002), and genetic disruption of both
resulting expression ratios were displayed relative to each otherDNMT1 and DNMT3B significantly inhibited methyltransferase
using a hierarchical clustering algorithm to indicate up- or down-activity and reduced genomic DNA methylation by roughly 95%
regulation (red: 1.5-fold upregulated; green: 1.5-fold down-(Rhee et al., 2000, 2002). In contrast, a single knockout of
regulated; black: no change). These results identify regions ofDNMT1 exhibited markedly decreased cellular DNA methyl-
differential response to pharmacological (Figure 1A) or genetictransferase activity with only modest global effects on methyla-
(Figure 1B) modification of methyltransferase activity.tion (20%) (Rhee et al., 2000). Others, using DNMT1/ mouse
fibroblasts, demonstrated significant changes in gene expres-
The effects of 5-aza-CdR closely resembled thosesion patterns (5%) when only a single methyltransferase was
of TSA, with subtle differencesdisrupted (Jackson-Grusby et al., 2001). Although these are
Previous experiments to determine the effects of 5-aza-CdR ordifferent systems, the results of these studies together suggest
TSA have focused on measurement of individual gene expres-that the change in gene expression may not reflect the degree
sion or have used microarray analysis with limited replication,of change in global methylation.
restricting statistical robustness. We attempted to overcomeDetermination of the relationship between DNA methylation
these limitations by analyzing the microarray expression profileand global changes in gene expression has not been previously
of HCT116 cells following their exposure to 5-aza-CdR and/oraddressed in a comprehensive manner. In one study, methyla-
TSA. A hierarchical cluster map for HCT116 cells treated withtion was examined using differential methylation hybridization
5-aza-CdR, TSA, or both, was constructed (Figure 1A).(DMH) and amplification of intermethylated sites (AMS) com-
Surprisingly, the responses of HCT116 cells to 5-aza-CdRbined with a 34 gene CpG island microarray (Paz et al., 2003).
(Figure 1A, column 3) and TSA treatment (Figure 1A, column 1)However, a microarray-based gene expression analysis and the
were very similar (r  0.84). In this case, r represents theeffects of 5-aza-CdR and TSA were not within the scope of that
Pearson’s correlation coefficient, an approximation of similaritystudy. To date, the only microarray-based approach to examine
between two distinct data points where a value of 1.0 representsthe regulation of the epigenome used RKO colon carcinoma
identical gene expression pattern (The black column left of col-cells treated with 5-aza-CdR followed by cDNA subtraction (Su-
umn 1 represents control, untreated HCT116 cells). This highzuki et al., 2002). However, in this study, no comparison to
degree of similarity is clearly seen when comparing columns 1DNMT knockout cells was done.
and 3 in areas I–IV, where there is an especially high r value.In the present study, we chose a combined approach em-
This similarity is also seen when comparing concurrent treat-ploying pharmacological and/or genetic manipulation to exam-
ment with both agents (column 2) to treatment with TSA orine the expression of a large number of genes. A rigorous statisti-
5-aza-CdR alone.cal analysis of microarrays was performed on HCT116,
Several examples of genes previously shown to be upregu-DNMT1/, DNMT3B/, and DKO cell lines, with and without
lated by exposure to either 5-aza-CdR or TSA include insulin-likeexposure to 5-aza-CdR, TSA, or both. This work was designed
growth factor 1 (IGF1), an autocrine growth factor (Furstenbergerto significantly expand upon previous studies referenced earlier
and Senn, 2002), platelet-derived growth factor- (PDGF-B),(Jackson-Grusby et al., 2001; Suzuki et al., 2002; Paz et al.,
which regulates pro-proliferative signaling pathways (Ulleras et
2003). To generate data that were statistically significant, valid,
al., 2001), and TRF-2 interacting telomeric RAP-1 protein
and reproducible, experiments were repeated in triplicate with (RAP1), implicated in a wide range of biological processes from
at least two microarrays per sample on nearly 8000 genes, cell proliferation, differentiation, and cell adhesion (Storks,
resulting in greater than 100 microarrays in total. The data were 2003). These genes, as well as others altered by the addition
analyzed in the context of existing knowledge about gene ex- of 5-aza-CdR and TSA, are shown (see Supplemental Table S4).
pression regulation by methylation status and methyltransferase The analysis of HCT116 cells treated with chemical agents
activity to uncover previously unknown relationships. also identified several genes not previously shown to be regu-
lated by chemical modification. These genes include pituitary
Results tumor-transforming factor (PTTG1) and peroxiredoxin 2 and 3
(PRDX2 and PRDX3). Multiple CpG islands are contiguous to
A gene expression clustering analysis algorithm or immediately upstream of these genes (identified using Entrez
applied to the epigenome Genome, National Center of Biotechnology Information). The
A hierarchical gene-based clustering algorithm was employed, results of these experiments suggest that the effects of 5-aza-
and sufficient statistical power was attained using multiple sub- CdR and TSA on gene expression are considerably more similar
clones, RNA collections, and microarray hybridizations for each than previously demonstrated, suggesting a common upstream
somatic knockout cell line. Accordingly, at least four RNA sam- pathway leading to altered gene expression.
ples per cell line and up to eight microarrays were used to
account for any potential clonal differences or RNA collection Chemical effects on gene expression patterns were
variability (see Supplemental Table S1 at http://www.cancercell. independent of dose and duration of exposure
org/cgi/content/full/6/4/361/DC1/), with or without experimental The results presented in Figure 1A represent a 24 hr exposure
to 10 M of 5-aza-CdR. To exclude the possibility that sometreatment with 5-aza-CdR or TSA. Genes were evaluated if they
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Table 1. Similarity of HCT116 and SW48 cells treated with 5-aza-CdR, TSA, or
butyrate, as demonstrated by Pearson’s correlation coefficient values (r)
1 M CdR 10 M CdR
HCT116 1d 5d 1d 5d TSA
1 M CdR 1d — — 0.983 0.998 0.761
5d 0.998 — 0.966 0.971 0.726
10 M CdR 1d — — 0.708
5d 0.956 — 0.733
5 mM butyrate 0.947 0.912 0.863 0.856 0.541
HCT116
1 M CdR 10 M CdR
SW48 1d 5d 1d 5d
1 M CdR 1d 0.976 — 0.972 —
5d — 0.970 — 0.971
10 M CdR 1d 0.977 — 0.974 —
5d — 0.962 — 0.911
Pearson’s correlation coefficient (r), an approximation of similarity be-
tween two distinct data points, where a value of 1.0 represents identical
gene expression pattern.
efficient values. This analysis demonstrated surprisingly little
variability in gene expression, comparing either time of exposure
or concentration of 5-aza-CdR, with differences in correlation
coefficients (r) between 0.95 and 0.99 (Table 1, upper panel).
Thus, while 5-aza-CdR minimally decreases cell growth rates
at one day and substantially at five days (see Supplemental
Table S5 at http://www.cancercell.org/cgi/content/full/6/4/361/
DC1/), very little difference in overall gene expression patterns
is evident comparing concentration or duration (Table 1, upper
panel). These results suggest that the global effects of 5-aza-
CdR on gene expression patterns are remarkably similar and
that nonspecific drug-induced toxicity is unlikely to account for
a significant fraction of the changes in gene expression after
5-aza-CdR.
Likewise, HCT116 cells were treated with sodium butyrate,
an alternative to TSA for inhibition of histone deacetylation, and
evaluated for similarity in gene expression patterns. TreatmentFigure 1. Hierarchical clustering of gene expression following pharmacologi-
with 5 mM of butyrate showed a strong similarity to that ofcal or genetic alteration of methyltransferase activity
HCT116 cells treated with 5-aza-CdR, with resulting Pearson’sA: Cluster map of HCT116 cells treated with 5-aza-CdR, TSA, or 5-aza-CdR
concurrent with TSA for 24 hr. Mean gene expression values were deter- correlation coefficient values between 0.947 and 0.856, de-
mined from experimental replicates, calculated as a ratio of HCT116 expres- pending on concentration and time (Table 1, upper panel). The
sion, and clustered hierarchically using Cluster (v. 2.20) and TreeView (v. r value of butyrate compared to TSA was 0.541 (Table 1, upper
1.60) software (Eisen and Brown, 1999). The left-most column represents the
panel). As an additional control, to rule out an idiosyncraticratio of untreated HCT116 to itself and is therefore black (indicating no
effect on HCT116 cells, we treated a second colon cancer cellchange). Column 1 represents the ratio of TSA-treated to untreated HCT116
cells, where red represents an increase in RNA message, green a decrease. line, SW48, with 5-aza-CdR, at both 1 and 10 M concentra-
Similar relationships were determined for the combination 5-aza-CdR and tions, and for both 1 and 5 days. The effect on gene expression
TSA (column 2) and the 5-aza-CdR treatment (column 3), relative to un-
patterns was again nearly identical between the two colon can-treated HCT116 cells.
cer cell lines, with r values between 0.91 and 0.97 resulting fromB: Gene expression of DNMT1/, DNMT3B/, and DKO cells, relative to
parental HCT116 cells. Gene expression data were clustered as described comparison of 5-aza-CdR treatments (Table 1, lower panel).
above and displayed relative to untreated, parental HCT116 cells. Column 1
represents the expression ratio of DNMT3B/ to HCT116, column 2 represents Silencing of genes by 5-aza-CdR or TSA
that of DKO to HCT116, and column 3 represents that of DNMT1/ to HCT116.
Since methylation acts to inhibit gene expression, and demeth-
ylating agents are believed to behave as negative regulators
and expression activators, most studies have examined only
genes that are upregulated following exposure to 5-aza-CdRof the changes in gene expression might be due to drug-induced
cytotoxicity, HCT116 cells were also treated with a lower con- and/or TSA. However, this study identified several genes that are
downregulated following exposure to 5-aza-CdR and/or TSA,centration (1 M) of 5-aza-CdR, as well as for varying durations
(both 1 and 5 days). Overall gene expression patterns at varying suggesting that methylation increases gene expression either
indirectly or directly. A hierarchical cluster analysis identifiedconditions were then compared using Pearson’s correlation co-
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Table 2. Similarity of somatic cell knockout cells to each other and to 5-aza-
CdR-treated HCT116 cells, as demonstrated by Pearson’s correlation coef-
ficient values (r)
DNMT1/ DNMT3B/ DKO
HCT116 0.22 0.63 0.32
DNMT1/ — 0.42 0.76
DNMT3B/ — — 0.52
Knockout cell line HCT116 DNMT1/ DNMT3B/
5-aza-CdR 0.71 0.42
Pearson’s correlation coefficient (r), an approximation of similarity be-
tween two distinct data points, where a value of 1.0 represents identical
gene expression pattern.
329 genes downregulated at least 1.5-fold by 5-aza-CdR, 154
genes by TSA, and 176 downregulated at least 1.5-fold following
exposures to both agents. These genes include interleukin en-
hancer binding factor (ILF3), cyclin B2 (CCNB2), and cyclin 25B
(CDC25B), c-myc binding protein (MYCBP), and hepatoma-
derived growth factor (HDGF), none of which have been pre-
viously shown to have altered expression to 5-aza-CdR or TSA
exposure. Upon examination, each of these genes was found
to contain a CpG island overlapping the transcriptional start site
(identified using Entrez Genome, NCBI). A complete list of genes
downregulated by chemical modification of methylation is avail-
able (see Supplemental Table S6). Among these, ILF3 has been
shown to interact with and is regulated by protein-arginine meth-
yltransferase-1 (PRMT1), the predominant intracellular protein- Figure 2. Real-time, RT-PCR verification of gene expression in parental and
arginine methyltransferase (Tang et al., 2000). The possible knockout cell lines
mechanism accounting for these results is unclear and may Validation of cDNA microarray data using the real-time, RT-PCR assay to
establish expression ratios between HCT116, DNMT1/, DNMT3B/, and DKOinclude either direct effects on CpG islands (e.g., insulator activ-
cell lines. Upregulated genes (A) and downregulated genes (B) are shown.ity) or indirect nonspecific effects of the chemical agents. The
The total RNA used for the real-time, RT-PCR assay was taken from one setresults of these experiments suggest that chemical agents that
of the three replicate experiments, and the real-time, RT-PCR data shown
inhibit methyltransferase activity or chromatin structure act both represent the average of three independent reactions.
to increase and to decrease the expression of specific genes.
DNMT1/ and DNMT3B/ cell lines showed
substantial differences in gene expression is available (see Supplemental Table S7). Curiously, DKO cells
(column 2) showed an intermediate change in the gene expres-To comprehensively address the effect of genetic inhibition of
methyltransferase on gene expression, values from untreated sion pattern between those of either single knockout cell line
(HCT116 versus DKO, r  0.32) (Table 2, upper panel). Thissomatic cell knockout lines for DNMT1/, DNMT3B/, and dou-
ble knockouts (DKO) were analyzed. The data were clustered interpretation was confirmed by a pairwise comparison of each
genotypes: DNMT1/ versus DNMT3B/ (r  0.42); DNMT1/in both directions (i.e., by genes and by cell lines), and an initial
analysis of the data clearly demonstrated distinct differences versus DKO (r  0.76); and DNMT3B/ versus DKO (r  0.52)
(Table 2, upper panel).between the DNMT1/, DNMT3B/, and DKO cell lines.
DNMT3B/ cells showed the fewest changes in gene expres- These results suggest that the effects of genetic disruption
of DNMT1 and DNMT3B on gene expression are not simplysion, relative to the parental HCT116 cells (Figure 1B). Examina-
tion of column 1 versus columns 2 and 3, in the areas designated additive, but likely involve a complex interplay between the
two pathways. These results may also resolve a controversyI and II, clearly shows fewer differences in up- or downregulated
genes in DNMT3B/ than either DNMT1/ or DKO cells, com- regarding the original observation of Rhee et al. (2002), who
found residual methyltransferase activity in their DNMT1 knock-pared to HCT116 cells. This is also reflected in the Pearson’s
correlation coefficient value for HCT116 versus DNMT3B/ out cell line. In the course of our analysis, we observed a 3.1-
fold increase in DNMT3B expression in DNMT1/ cells, sug-(r  0.63) (Table 2, upper panel), indicating a moderate similar-
ity in gene expression patterns (see Supplemental Table S7 for gesting a potential compensatory upregulation of DNMT3B
gene expression to offset the functional loss of DNMT1.raw values).
In contrast, DNMT1/ cells showed the greatest number of
genes with differential expression (HCT116 versus DNMT1/, Validation of microarray data
To further confirm the results of microarray analysis, real-time,r  0.22) (Table 2, upper panel). This is seen when comparing
column 3 in the areas designated I and II with column 1 or 2 quantitative reverse transcription (RT) PCR analysis was con-
ducted for 13 randomly selected genes from the HCT116,(Figure 1B). A complete analysis of gene expression patterns
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Figure 3. Hierarchical clustering of gene expres-
sion in DNMT1/ knockout cells by pharmacolog-
ical alteration with 5-aza-CdR and/or TSA
A: Ratios of gene expression values were gener-
ated and clustered hierarchically as described
in Figure 1. Up- (i.e., red) and down- (i.e., green)
regulation identified gene responsiveness to
5-aza-CdR and/or TSA treatment unique to the
genetic knockouts. The black, left-most column
represents control, HCT116 cells.
B and C: Yellow boxes denote boundaries of the
clusters. B: Genes upregulated in the DNMT1
knockout that are either drug-responsive or drug-
unresponsive are shown. C: Genes down-
regulated in the DNMT1 knockout that are ei-
ther drug-responsive or drug-unresponsive are
shown. NCBI abbreviations and gene names
shown in the respective clusters, as enclosed by
yellow rectangles, are not inclusive of all genes
within the cluster box.
DNMT1/, DNMT3B/, and DKO cell lines. The total RNA used ated, as well as a similar map of the DNMT1/, DNMT3B/,
and HCT116 somatic cell lines exposed to either 5-aza-CdR orfor the RT-PCR experiments were taken from one set of the
three replicate experiments, and the RT-PCR data shown repre- TSA (Figure 3A). The DKO cells could not be treated with either
sent the average of three independent reactions. Upregulated 5-aza-CdR or TSA, due to cell death as early as 24 hr following
(Figure 2A) and downregulated (Figure 2B) genes are shown, as start of treatment. Using Pearson’s correlation, the pattern of
are the sequences of primers and probes used (see Supplemental gene expression in HCT116 cells treated with 5-aza-CdR more
Table S8). Comparison of the real-time, RT-PCR results showed closely resembled that of the DNMT1/ cells (r  0.71, Table
a complete (100%) concurrence in terms of increases or decreases 2, lower panel) than DNMT3B/ cells (r  0.42, Table 2, lower
in gene expression with those measured using the microarray panel). Thus, the DNMT1 knockout more closely approximates
data, with no more than a 25% difference in relative values. Thus, the effects of 5-aza-CdR on gene expression than does the
results of the experiments in Figure 2 indicate an excellent agree- DNMT3B knockout.
ment between the microarray and real-time, RT-PCR analyses. Based on this result, we grouped target genes into four
distinct classifications: those genes (1) upregulated by methyl-
transferase knockout and by 5-aza-CdR and TSA; (2) upregu-Gene expression patterns after chemical and genetic
inhibition of methyltransferase differed lated by methyltransferase knockout but unaffected by 5-aza-
CdR and TSA; (3) downregulated by methyltransferase knockoutIn order to compare the effects on gene expression of chemical
inhibition with genetic knockout of methyltransferase activity, a and by 5-aza-CdR and TSA; and (4) downregulated by methyl-
transferase knockout but unaffected by 5-aza-CdR and TSAhierarchical cluster map of the DNMT1/, DNMT3B/, and DKO
somatic cell lines versus the parent HCT116 cells was gener- (Figure 3B). Genes upregulated by both methyltransferase
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Figure 4. Cell growth rates and apoptosis in
HCT116, DNMT1/, DNMT3B/, and DKO cell lines
A–C: HCT116 (A), DNMT1/ (B), and DNMT3B/
(C) cells were plated at 20,000 cells per 35 mm
dish, treated continuously with 5-aza-CdR (1 or
10 M), and subsequently counted at 1, 2, 3, 4,
and 5 days to determine cell growth rates.
D: Results of Annexin V-FITC detection of apopto-
sis in HCT116, DNMT1/, DNMT3B/, and DKO fol-
lowing exposure to 10 M of 5-aza-CdR. Cells
were treated for 24 hr, and Annexin V-FITC was
added to the cell suspension following incu-
bated at room temperature for 15 min in dark.
Samples were kept on ice in dark and analyzed
by flow cytometry using Cell Quest and ModFit
software. 10,000 events were collected for analy-
sis. The asterisk identifies statistically significant dif-
ferences (p 0.05 by two-tailed Student’s t test).
knockout and drug treatment included members of the major CdR exposure at 1 and 10 M for 1 through 5 days. Proliferation
histocompatibility complex antigen (HLA) gene family, pre- assays (Figures 4A–4C) clearly showed that 5-aza-CdR de-
viously shown to be modulated by DNMT1 (Nie et al., 2001; creases cell growth in all three cell lines, particularly at increasing
Guillaudeux et al., 1996). Several additional genes were found times of exposure, and that the degree of growth delay is very
which clustered with the HLA genes; these include -2-micro- similar among each cell line at identical concentrations (Figures
globulin (B2M), neuromedin B-receptor (NMBR), solute carrier 4A–4C). DKO cells were not tested, due to significant drug-
family 26 (SLC26A3, a chloride pump), and trefoil factor 1 (TFF1). induced cytotoxicity. Further experiments indicated that inci-
Of these, SLC26A3 and TFF1 are particularly interesting, given dence of apoptosis was unchanged in the HCT116, DNMT1/,
the recent report that a family member of SLC26A3, SLC5A8, and DNMT3B/ cells following exposure to 10 M of 5-aza-
has been identified as a tumor suppressor gene in colon cancer, CdR (Figure 4D). Nevertheless, as described earlier, the pattern
and TFF1 has been identified as a putative tumor suppressor of gene expression after 5-aza-CdR was largely independent
gene with a methylated promoter in some gastric cancers (Car- of dose and time of exposure. Therefore, the changes in gene
valho et al., 2002). Genes upregulated by methyltransferase expression are not secondary to changes in cell growth and
knockout but not by drug treatment included the bone develop- apoptosis.
ment gene matrillin-4 (MATN4) and a member of the cathepsin
gene family (CTSL2), which is involved in antigen processing.
Hypomethylation of the APM2 promoter is associatedComplete lists of drug-responsive and -unresponsive genes are
with gene silencingavailable for both DNMT1/ and DNMT3B/ (Figure 3B and
Previously, the loss of methylation of gene promoters with in-see Supplemental Table S9).
creased gene expression was demonstrated in DNMT somatic
knockout cell lines (Rhee et al., 2002). One of the surprising5-aza-CdR effects on gene expression were
results of the present study was the identification of a subsetindependent of cell proliferation and apoptosis
of genes whose gene expression was decreased by loss ofCellular proliferation rates and apoptosis were determined for
the HCT116, DNMT1/, and DNMT3B/ cell lines after 5-aza- methylation. In order to confirm an alteration in DNA methylation,
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Metallothionein family genes constitute a cluster
of differentially expressed genes
One of the purposes of this analysis was to determine whether
methylation alterations could affect expression of clusters of
genes, as suggested by recent studies of the effect of chromatin
insulators on gene domains (Holmgren et al., 2001). To address
this objective, a new analytical method was employed, which
systematically searches the physical and genetic locations of
differentially expressed genes for apparent clusters or groups
of closely spaced, coregulated genes, and determines the statis-
tical significance of such findings (as described in detail in the
Experimental Procedures below and in the Supplemental Exper-
imental Procedures at http://www.cancercell.org/cgi/content/
full/6/4/361/DC1/). We uncovered one site of regional gene clus-
tering, located at 16q13 (Figure 6A), and found five genes which
were members of the same metallothionein (MT) gene family
(Figure 6B, genes in bold). The other genes listed are either
pseudogenes or not present on the microarray.
Several members of the metallothionein family have been
previously shown to be regulated by methylation (Ghoshal et
al., 2000; Majumder et al., 2002), and a regional analysis of
methylation patterns in this segment of the genome clearly re-
vealed the presence of multiple, strict ( 500 bp long, 50% or
higher CG content) CpG islands (identified using Entrez Ge-
nome, NCBI; Figure 6B). However, several of the genes involved
do not have a CpG island in the direct areas of either the open
reading frame or the upstream regulatory region. These results
suggest a novel mechanism involving methylation-induced re-
gional chromosomal structural changes that alter the expression
of a class of related genes colocalized to a specific chromo-
somal region.
Figure 5. The APM2 promoter CpG island is hypomethylated in somatic cell
methyltransferase knockout cell lines Discussion
A: The methylation status of the CpG island in the APM2 upstream promoter
region was determined in HCT116, DNMT1/, DNMT3B/, and DKO cell lines This study represents a comprehensive integrated experimental
as well as HCT116, DNMT1/, and DNMT3B/ treated with 5-aza-CdR for approach to the cancer epigenome, comparing the effects on
24 hr.
gene expression of altered DNA methyltransferase activity dueB: The APM2, SSFA2, CD44, AREF, and PDE4B promoters were examined for
to genetic knockout of DNMT1, DNMT3B, or both, to those ofthe presence of CpG islands and CTCF binding sites using software available
at Entrez Genome (http://ncbi.nlm.nih.gov) and the Genetics Computer pharmacological manipulation. We performed extensive repli-
Group (http://helix.nih.gov), respectively. cate experiments with multiple clones, cell lines, drug concen-
trations, and durations. The outcomes of this analysis yielded
four major findings.
First, we were surprised to find that the effects of 5-aza-
we examined the promoter region of APM2, which was shown CdR on gene expression more closely resembled those of TSA
than either of the somatic cell DNA methyltransferase knock-to be silenced in the somatic knockout cell lines, and found
outs, implying a converging mechanism for these agents. Thethat the degree of transcriptional silencing closely reflected the
effects on gene expression we observed were also remarkablydegree of hypomethylation observed in the APM2 promoter
consistent across dosage and duration of drug exposure and(compare Figures 2B and 5A). Surprisingly, both the hypometh-
were largely independent of cell growth. Specifically, 5-aza-ylation and the decrease in gene expression were observed at
CdR effects were similar at one and five days. These data do24 hr of treatment with 5-aza-CdR (after 1–2 cell divisions at
not fit the conventional view that 5-aza-CdR acts on gene ex-most), suggesting some form of active of active demethylation,
pression solely by incorporation into DNA during one cell divi-
rather than only passive demethylation, as might be expected.
sion, followed by loss of methylation during subsequent rounds
It has been suggested that the CTCF insulator protein can of replication. Rather, it suggests some form of active demethyl-
block the transcriptional activity of enhancer elements (Bell et ation and/or perturbations of chromatin structure that affect
al., 1999; Bell and Felsenfeld, 2000; Hark et al., 2000, Holmgren gene expression. One possible mechanism might be an active
et al., 2001), which could lead to hypomethylation-associated demethylase in cells, as has been suggested by others (Keshet
gene silencing. Consistent with this idea, all of the downregu- et al., 1986; Litt et al., 1997; Collas, 1998; Falk and Ernberg,
lated genes confirmed by real-time PCR (Figure 2B) contained 1999). Alternatively, both drugs could directly influence the sta-
a CpG island and at least one nearby consensus CTCF binding bility of methylation and/or chromatin marks either directly or
through their modifying proteins.site (Figure 5B).
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Figure 6. Metallothionein family genes constitute
a cluster of differentially expressed genes
A: Diagram of chromosome 16 and the area of
interest on 16q13.
B: Metallothionein genes upregulated in the DKO
cells as well as other metallothionein genes in the
chromosomal region of interest. Genes shown to
be upregulated appear in bold, while the other
metallothionein genes were not present on the
microarray. Strict and relaxed CpG islands (as
defined by NCBI) are denoted by gray and dot-
ted boxes, respectively. Gene transcripts are
shown with putative open reading frame as de-
noted by gray hash marks to the left of the NCBI
abbreviation gene name.
Presently, the only other microarray study evaluating the difference between those from the effect of DNMT knockout,
as described above. Suzuki et al. (2002) suggested that theeffects of 5-aza-CdR or 5-aza-CdR and TSA on the modulation
of gene expression did not compare the results to DNMT knock- effects of 5-aza-CdR were additive to those of TSA because of
a distinct mechanism of action. However, the results presentedout cells or look for downregulated genes after exposure (Suzuki
et al., 2002). In that study, a combined cDNA subtraction/ here would argue that the pathways of action of these agents
are overlapping.microarray technique was used to increase the specificity of
gene identification at the expense of sensitivity. In addition, the The second major result is that the effects of the DNMT1/
and DNMT3B/ knockouts on gene expression overlappedconcentration of 5-aza-CdR (200–300 nM) was considerably
lower than generally used to modulate gene expression, which each other in many cases, but also exhibited significant differ-
ences. DNMT1/ altered total intracellular gene expression pat-may explain the small number of genes upregulated (74 genes)
after exposure (Suzuki et al., 2002). Nevertheless, 70% of the terns to a much greater extent than that observed for the
DNMT3B/ knockout cells, suggesting that it is the dominantgenes identified in that study (which were also present on our
gene set) were also shown to be upregulated following chemical methyltransferase in this model system. In addition, the changes
in gene expression in the DKO cells were less than those seenexposure in our study. The difference between the two studies
for the remaining 30% may be accounted for by the methodol- in DNMT1/, suggesting a potential antagonistic mechanism
between DNMT1- and DNMT3B-regulated genes.ogy of validation, semiquantitative versus real-time quantitative
PCR in our study, and cell lines. Another important difference Comparing the results from the present study to data on
global methylation of DNMT knockout lines (Rhee et al., 2002),revealed by our epigenomic approach was the similarity be-
tween the effects of 5-aza-CdR and TSA, and the substantial it appears that the extent of changes in global methylation were
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not closely related to the specific changes in gene expression. stream regulatory region. In addition, with more detailed gene
arrays, there are likely to be additional such clusters, since theThus, we found substantial changes in gene expression even
in single knockout lines, in spite of modest changes in global expression arrays were not designed a priori to identify them.
Thus, an area for further research suggested by these experi-methylation. Furthermore, the pattern of gene expression was
similar in our hands in the DKO cells, even though they under- ments will be the identification of gene clusters that show coor-
went substantial global hypomethylation. dinated changes in expression regulated by methylation or chro-
The specificity of DNMT-regulated gene expression is sup- matin, and the elements responsible.
ported by a comparison of the data derived here to the results
Experimental proceduresfound in DNMT1/ mouse fibroblasts. There was considerable
similarity between the changes in expression of the genetic
Cell culture and exposure to 5-aza-2-Deoxycytidine
knockout that we observed, and a microarray analysis of and/or Trichostatin A
DNMT1/ mouse embryo fibroblasts (Jackson-Grusby et al., Multiple clones of the DNMT1 knockout cell line (DNMT1/), DNMT3B
2001), with substantial overlap in the patterns of gene expres- knockout cell line (DNMT3B/), DNMT1 and DNMT3B (double) knock out
cell line (DKO), and parental colon cancer cell line (HCT116) were constructedsion (62%). In addition, the HCT116 DNMT1/ cells showed
as described (Rhee et al., 2002) and grown in McCoy’s 5A medium (In-increased doubling times and inherent apoptosis levels similar
vitrogen, Grand Island, NY). At least two cell clones were used in separateto those reported for the DNMT1/ mouse fibroblasts cells
experiments to isolate RNA samples, and two microarrays were run on(Jackson-Grusby et al., 2001), suggesting that DNMT1 effects
each RNA sample to account for cell line, RNA extraction, and microarray
are generalized across cell types and species. hybridization variability. Cell lines were passaged with about 50% confluence
Third, a substantial fraction of genes were downregulated six hours before treatment. Cells were treated with designated doses of
rather than upregulated after chemical and genetic manipula- 5-aza-2	-deoxycytidine (5-aza-CdR; Sigma, St. Louis, MO), 100 ng/ml of
Trichostatin A (TSA; Sigma, St. Louis, MO), or 5 mM of butyrate (Sigma,tions, suggesting that hypomethylation decreased gene expres-
St. Louis, MO). The medium containing drugs was changed every day.sion in these cases. Consistent with this hypothesis, analysis
Confluence of collected cells was not more than 80%.of the APM2 gene promoter showed a decreased degree of
methylation as the methyltransferase genes were deleted (Fig-
RNA extraction
ure 5A), and this correlated with the degree of decrease in gene Total cellular RNA was isolated using ISOGEN (Maarssen, The Netherlands),
expression (Figure 2B). A potential mechanism for hypomethyla- according to the protocol supplied by the manufacturer. RNA was further
tion-mediated silencing is an insulator effect in chromatin. For purified using RNeasy Mini kit according to the manufacturer’s recommenda-
tions (QIAGEN, Valencia, CA) with addition of DNase Digestion with RNase-example, CTCF, a chromatin insulator protein, binds to unmeth-
free DNase set (QIAGEN, Valencia, CA). Purity was determined by gel analy-ylated GC-rich sequences, causing their silencing by separating
sis and spectrometrically. Reverse transcription and quantitative real-timeenhancers from promoter elements (Fedoriw et al., 2004;
PCR were carried out as described (Cui et al., 2001; Ravenel et al., 2001).Schoenherr et al., 2003), and consensus CTCF binding sites
were found in all of the genes that exhibited downregulation Probe labeling, microarray hybridization,
(Figure 2B, Figure 5B). Thus, it will be important to investigate and image and data analysis
the role in cancer of the large number of normally methylated Methodologies for the probe labeling reaction and microarray hybridization
are previously described (Chuang et al., 2002). The microarrays used forCpG islands that were recently identified (Strichman-Almashanu
this study contained 7,680 human cDNA clones and were prepared fromet al., 2002).
the Research Genetics (Huntsville, AL) Named Genes set. These cDNAA surprising finding from the microarray analysis comparing
clones are enriched for known genes. All 7,680 cDNAs were spotted ontoand contrasting the effects of chemical and genetic modification
poly-L-lysine-coated slides (NCI ROSP 8k Human Array) using an OmniGrid
of methyltransferase activity revealed a group of genes in which arrayer (GeneMachines, San Carlos, CA) (Eisen and Brown, 1999). Microar-
5-Aza-CdR or TSA effects were opposite to those of DNMT1 rays were scanned at 10 m resolution on a GenePix 4000A scanner (Axon
and/or DNMT3B knockout. This paradoxical effect on gene Instruments, Inc., Foster City, CA). The Cy5- and the Cy3-labeled cDNA
samples were scanned at 635 nm and 532 nm, respectively. The resultingexpression is most striking in DNMT1/ cells exposed to
TIFF images were analyzed by GenePix Pro 3.0 software (Axon Instruments,5-Aza-CdR or TSA (see Supplemental Figure S1 at http://www.
Inc., Foster City, CA).cancercell.org/cgi/content/full/6/4/361/DC1/), as shown in re-
The ratios of the sample intensity to the reference intensity (green [Cy3]/
gions IV and VII. For example, 11 genes were upregulated and red [Cy5]) for all targets were determined. Since a normal distribution could
33 genes were downregulated paradoxically in the DNMT1 not be applied to all components of the data set, a Mann-Whitney test
knockout treated with 5-aza-CdR or TSA, respectively (see Sup- was used to ascertain statistical significance among microarray replicates
(Troyanskaya et al., 2002). Well fluorescence was corrected for backgroundplemental Table S10). Similar results were observed for chemical
fluorescence, and ratios of intensity were established relative to appropriatetreatment of the DNMT3B/ cells. This reinforces the idea that
controls. We selected a 1.5-fold threshold in differences because the multiplepharmacological manipulation may not be equivalent to the ge-
repeats in our experimental scheme increase the likelihood of statisticalnetic knockout of DNMT.
reliability. Three additional analytical methods were employed to validate
Finally, in at least one case, we identified a gene cluster statistical integrity: class comparison, class prediction, and false discovery,
belonging to the metallothionein family, spanning at least 76 all preformed at p  0.05 to validate statistical integrity (See Supplemental
kb, which showed coordinate regulation. These results suggest Tables S2 and S3 at http://www.cancercell.org/cgi/content/full/6/4/361/
DC1/).a novel mechanism involving methylation-induced regional
In some cases, additional genes were included so that the hierarchalchromosomal structural changes altering the expression of a
cluster map would show novel clusters of important genes. Importantly, weclass of related genes colocalized to a specific chromosomal
do not refer to individual genes as only increased by 1.5-fold, but rather toregion. While several members of this gene family have been
gene clusters based on the multiple experimental conditions. In most cases,
shown to be regulated by methylation (Ghoshal et al., 2000; at least one of the conditions had increases greater than 2-fold or decreases
Majumder et al., 2002), other family member genes do not con- less than 2-fold. Pearson’s moment correlation coefficients (r) were calcu-
lated from fluorescent ratio data and relate the overall similarity in genetain CpG islands in either the open reading frame or the up-
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Bestor, T.H. (2000). The DNA methyltransferases of mammals. Hum. Mol.expression patterns between the two data sets under comparison. Values
Genet. 9, 2395–2402.of r range from 1 (no correlation) to 1 (complete correlation).
Carvalho, R., Kayademir, T., Soares, P., Canedo, P., Sousa, S., Oliveira, C.,
Proliferation and apoptosis assays Leistenschneider, P., Seruca, R., Gott, P., Blin, N., et al. (2002). Loss of
For proliferation assays, cells were seeded at a density of 2 
 104 cells per heterozygosity and promoter methylation, but not mutation, may underlie
35 mm dish and returned to a humidified 37C, 5% CO2 incubator for growth. loss of TFF1 in gastric carcinoma. Lab. Invest. 82, 1319–1326.
Designated samples contained 5-aza-CdR at 1 or 10 M concentrations in
Chuang, Y.Y.E., Chen, Y., Gadisetti, C., Chandramouli, V.R., Cook, J.A.,the media. For the following days, three plates from each treatment condition
Coffin, D., Tsai, M.H., DeGraff, W., Yan, H., Zhao, S., et al. (2002). Genewere trypsinized and quantified via a Z2 Counter (Beckman-Coulter, Fuller-
expression after treatment with hydrogen peroxide, menadione, or t-butylton, CA), with fresh medium added daily. Growth curves were plotted as
hydroperoxide in breast cancer cells. Cancer Res. 62, 6246–6254.
the mean number of cells per dish as a function of time (d).
Assays for apoptosis detection and measurement were performed ac- Collas, P. (1998). Modulation of plasmid DNA methylation and expression
in zebrafish embryos. Nucleic Acids Res. 26, 4454–4461.cording to the manufacturer’s instructions (Annexin V-FITC Apoptosis Detec-
tion Kit, Oncogene Research, San Diego, CA). Data from 10,000 events were
Cui, H., Niemitz, E.L., Ravenel, J.D., Onyango, P., Brandenburg, S.A., Loba-
collected on a FACSCalibur cytometer (BD Immunocytometry, Fullerton, CA) nenkov, V.V., and Feinberg, A.P. (2001). Loss of imprinting of insulin-like
and analyzed using CellQuest/ModFit software. Results for early and late growth factor-II in Wilms’ tumor commonly involves altered methylation but
apoptosis were summed to calculate the total amount of apoptosis from not mutations of CTCF or its binding site. Cancer Res. 61, 4947–4950.
two time points. Samples treated with camptothecin (4 M, 42 hr; Sigma,
Cui, H., Cruz-Correa, M., Giardiello, F.M., Hutcheon, D.F., Kafonek, D.R.,St. Louis, MO) were used as positive controls.
Brandenburg, S., Wu, Y., He, X., Powe, N.R., and Feinberg, A.P. (2003).
Loss of IGF2 imprinting: A potential marker of colorectal cancer risk. ScienceBisulfite sequencing analysis
299, 1753–1755.The CpG island located on the promoter and 5	 of the APM2 gene was
obtained from the University of California, Santa Cruz Genome Bioinformat- Egger, G., Liang, G., Aparicio, A., and Jones, P.A. (2004). Epigenetics in
ics Site (http://www.genome.ucsc.edu) and corresponds to GenBank nucle- human disease and prospects for epigenetic therapy. Nature 429, 457–463.
otides 2417–3096 (NCBI Accession: AL136982). After bisulfite treatment,
Eisen, M.B., and Brown, P.O. (1999). DNA arrays for analysis of gene expres-DNA methylation was analyzed by PCR sequencing using primers 5	-GAAG
sion. Methods Enzymol. 303, 179–205.
TTATGGTAAGTAAGGGTTTGTAG-3	 and 5	-TCCCTATCCTAAACCTTCAC
CCTCTCCTA-3	, followed by 5	-TGTAGGATTTGAAGTAATAGGTG-3	 and Falk, K.I., and Ernberg, I. (1999). Demethylation of the Epstein-barr virus
origin of lytic replication and of the immediate early gene BZLF1 is DNA5	-CCAACATAACCTCCTTAAAAAAACTCC-3	, both annealing at 55C.
replication independent. Brief report. Arch. Virol. 144, 2219–2227.Other conditions are as described previously (Cui et al., 2003).
Fedoriw, A.M., Stein, P., Svoboda, P., Schultz, R.M., and Bartolomei, M.S.
Genomic location analysis: Apparent clusters (2004). Transgenic RNAi reveals essential function for CTCF in H19 gene
This approach is described in some detail, as this analysis represents the imprinting. Science 303, 238–240.
first location cluster of differentially expressed genes identified. This was
Feinberg, A.P., and Tycko, T. (2004). Timeline: The history of cancer epige-developed by L.Y. and P.J.M. at CIT/NIH, and the method has not been
netics. Nat. Rev. Cancer 4, 1–11.reported previously. The method involves finding a dense cluster, or closely
spaced set of coregulated genes, and determines the statistical significance Feinberg, A.P., and Vogelstein, B. (1983). Hypomethylation distinguishes
of such findings. The method is completely defined in the Supplemental genes of some human cancers from their normal counterparts. Nature 301,
Experimental Procedures at http://www.cancercell.org/cgi/content/full/6/4/ 89–92.
361/DC1/. Using numerical simulation with 10,000 iterations, the probability
Furstenberger, G., and Senn, H.J. (2002). Insulin-like growth factors andof observing a cluster with the same or more genes in the same or smaller
cancer. Lancet Oncol. 3, 298–302.span of DNA sequence, within a chromosome of the same length, containing
the same number of genes as the found cluster, is determined. The method Ghoshal, K., Majumder, S., Li, Z., Dong, X., and Jacob, S.T. (2000). Suppres-
correctly accounts for the nonuniform spacing of genes within chromo- sion of metallothionein gene expression in a rat hepatoma because of pro-
somes, and the multiple comparisons inherent in searching for clusters of moter-specific DNA methylation. J. Biol. Chem. 275, 539–547.
an unknown number of genes (see Supplemental Experimental Procedures).
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